Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma
Titel:
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma
Auteur:
Elaidi, R. Harbaoui, A. Beuselinck, B. Eymard, J.-C. Bamias, A. De Guillebon, E. Porta, C. Vano, Y. Linassier, C. Debruyne, P.R. Gross-Goupil, M. Ravaud, A. Aitelhaj, M. Marret, G. Oudard, S.